Clear Trail Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.8M Buy
11,377
+1,622
+17% +$646K 0.73% 43
2026
Q2
$3.53M Buy
9,755
+216
+2% +$73.9K 0.54% 53
2026
Q1
$3.36M Buy
9,539
+1,480
+18% +$528K 0.56% 50
2025
Q4
$2.64M Buy
+8,059
New +$2.56M 0.61% 42

Other funds holding AMGN

Clear Trail Advisors's AMGN Position: Q3 2026 in Review

Clear Trail Advisors increased its Amgen (AMGN) stake by 17% in Q3 2026, buying an estimated $646K and bringing the position to 11,377 shares worth $4.8M. The position accounts for 0.73% of the portfolio, ranked #43.

Clear Trail Advisors first reported a position in AMGN in Q4 2025 and has held it in 4 quarters since. 3,268 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Clear Trail Advisors held 11,377 shares of Amgen worth $4.8M as of Q3 2026.
  • Clear Trail Advisors bought 1,622 Amgen shares in Q3 2026, an estimated $646K.
  • Amgen made up 0.73% of Clear Trail Advisors's portfolio in Q3 2026, its #43 holding.
  • Clear Trail Advisors first reported a position in Amgen in Q4 2025 and has held it in 4 quarters since.
  • 3,268 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Clear Trail Advisors's 13F filing for Q3 2026, filed 20 Oct 2026.